This critical statistic illustrates why we need to pursue novel approaches to help reduce the morbidity and mortality associated with #CF. We support the Cystic Fibrosis Foundation’s leadership in advocating for everyone affected by this chronic condition. And we're doing our part to introduce #innovation that could help reduce the severity of respiratory infections and improve quality of living for more people with CF. #cysticfibrosis
According to 2023 Patient Registry data, the median predicted age of survival for people with cystic fibrosis born between 2019-2023 is 61. The prediction is based on people who participated in the Foundation’s Patient Registry between 2019 and 2023. This median predicted survival age is the age beyond which we expect 50% of babies with CF born between 2019-2023 to live, assuming no changes to currently available CF treatments. While we are proud of this continued improvement, we recognize that this longer lifespan does not represent the experience for everyone with CF. And median predicted survival for everyone with CF is still well below the overall life expectancy for the overall U.S. population. Quality of life — not just quantity — is tremendously important. We’re working harder than ever to develop transformative treatments for all people with CF and support high-quality, specialized care across our care center network.